Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy
ACS Nano · 13.06.2023 · 17 (11) · 9826-9849
DOI: 10.1021/acsnano.3c02273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 19.05.2023. Verfasst von Liuzhou Mao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sci…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Cancer Vaccines. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 192 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Science and Engineering Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.
- BE/Phase I Clinical Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road, Jurong Island, Singapore 627833, Republic of Singapore.
- Department of Materials Science and Engineering, National University of Singapore, 9 Engineering Drive 1, Singapore 117576, Republic of Singapore.
ORCID-Profile: Enyi Ye, Xian Jun Loh, Yun-Long Wu, Zibiao Li
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Science and Engineering Research Council
- Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang
Zitieren
APA
Mao, L., Ma, P., Luo, X., Cheng, H., Wang, Z., Ye, E., Loh, X. J., Wu, Y. L., & Li, Z. (2023). Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy. ACS Nano, 17(11), 9826-9849. https://doi.org/10.1021/acsnano.3c02273
Vancouver
Mao L, Ma P, Luo X, Cheng H, Wang Z, Ye E, et al. Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy. ACS Nano. 2023;17(11):9826-9849. doi:10.1021/acsnano.3c02273
BibTeX
@article{Mao2023,
author = {Mao, Liuzhou and Ma, Panqin and Luo, Xi and Cheng, Hongwei and Wang, Zhanxiang and Ye, Enyi and Loh, Xian Jun and Wu, Yun-Long and Li, Zibiao},
title = {Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {11},
pages = {9826--9849},
doi = {10.1021/acsnano.3c02273}
}
EUVIMED